JOANNA MAY: Open Payments
NPI 1588003495 · FAIRFAX, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,875 in 65 payments from 14 companies in 2025. Trend: 2023 $568 · 2024 $1,425 · 2025 $1,875
Food & beverage: $1,875
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $375 |
| Janssen Biotech, Inc. | 11 | $362 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $211 |
| Celltrion USA Inc. | 2 | $188 |
| Ardelyx, Inc. | 5 | $122 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $119 |
| PFIZER INC. | 4 | $115 |
| Lilly USA, LLC | 4 | $94 |
| Gilead Sciences, Inc. | 3 | $73 |
| Madrigal Pharmaceuticals | 2 | $72 |
Products named: TREMFYA, XIFAXAN, VEGZELMA, RINVOQ, IBSRELA, SKYRIZI, OMVOH, ENTYVIO.
Industry payments across VA — which companies pay providers there.
